chr19-38517534-C-T
Variant names: 
Variant summary
Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP4_ModerateBP6_Very_StrongBP7
The NM_000540.3(RYR1):c.9861C>T(p.Arg3287Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000192 in 1,613,758 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
 Genomes: 𝑓 0.000013   (  0   hom.,  cov: 31) 
 Exomes 𝑓:  0.000020   (  0   hom.  ) 
Consequence
 RYR1
NM_000540.3 synonymous
NM_000540.3 synonymous
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  -4.19  
Publications
0 publications found 
Genes affected
 RYR1  (HGNC:10483):  (ryanodine receptor 1) This gene encodes a ryanodine receptor found in skeletal muscle. The encoded protein functions as a calcium release channel in the sarcoplasmic reticulum but also serves to connect the sarcoplasmic reticulum and transverse tubule. Mutations in this gene are associated with malignant hyperthermia susceptibility, central core disease, and minicore myopathy with external ophthalmoplegia. Alternatively spliced transcripts encoding different isoforms have been described. [provided by RefSeq, Jul 2008] 
RYR1 Gene-Disease associations (from GenCC):
- malignant hyperthermia, susceptibility to, 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Genomics England PanelApp, Ambry Genetics
- congenital multicore myopathy with external ophthalmoplegiaInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp
- RYR1-related myopathyInheritance: AR, AD Classification: DEFINITIVE Submitted by: ClinGen
- central core myopathyInheritance: AD, AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
- King-Denborough syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- malignant hyperthermia of anesthesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- autosomal recessive centronuclear myopathyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- benign Samaritan congenital myopathyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- congenital myopathy with myasthenic-like onsetInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- lethal multiple pterygium syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -11 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.45). 
BP6
Variant 19-38517534-C-T is Benign according to our data. Variant chr19-38517534-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 256589.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BP7
Synonymous conserved (PhyloP=-4.19 with no splicing effect.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.0000131  AC: 2AN: 152132Hom.:  0  Cov.: 31 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
2
AN: 
152132
Hom.: 
Cov.: 
31
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.0000201  AC: 5AN: 248696 AF XY:  0.0000223   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
5
AN: 
248696
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.0000198  AC: 29AN: 1461626Hom.:  0  Cov.: 34 AF XY:  0.0000179  AC XY: 13AN XY: 727128 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
29
AN: 
1461626
Hom.: 
Cov.: 
34
 AF XY: 
AC XY: 
13
AN XY: 
727128
show subpopulations 
African (AFR) 
 AF: 
AC: 
0
AN: 
33480
American (AMR) 
 AF: 
AC: 
0
AN: 
44702
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
26110
East Asian (EAS) 
 AF: 
AC: 
12
AN: 
39696
South Asian (SAS) 
 AF: 
AC: 
3
AN: 
86252
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
53372
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
5768
European-Non Finnish (NFE) 
 AF: 
AC: 
12
AN: 
1111872
Other (OTH) 
 AF: 
AC: 
2
AN: 
60374
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.499 
Heterozygous variant carriers
 0 
 3 
 5 
 8 
 10 
 13 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.0000131  AC: 2AN: 152132Hom.:  0  Cov.: 31 AF XY:  0.00  AC XY: 0AN XY: 74312 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
2
AN: 
152132
Hom.: 
Cov.: 
31
 AF XY: 
AC XY: 
0
AN XY: 
74312
show subpopulations 
African (AFR) 
 AF: 
AC: 
0
AN: 
41414
American (AMR) 
 AF: 
AC: 
0
AN: 
15276
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3470
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5180
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
4830
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10632
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
316
European-Non Finnish (NFE) 
 AF: 
AC: 
2
AN: 
68010
Other (OTH) 
 AF: 
AC: 
0
AN: 
2092
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.575 
Heterozygous variant carriers
 0 
 0 
 1 
 1 
 2 
 2 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
ClinVar
Significance: Likely benign 
Submissions summary: Benign:3 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not specified    Benign:1 
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Malignant hyperthermia, susceptibility to, 1    Benign:1 
May 15, 2023
All of Us Research Program, National Institutes of Health
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
RYR1-related disorder    Benign:1 
May 10, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.